How High Will Eli Lilly Stock Go By 2030?
The weight loss drugs market is heating up quickly and…
Sell
29
AI Quote, Financials, Valuation and Earnings
Last price:
$19.85
Seasonality move
:
22.43%
Day range:
$19.32 - $20.00
52-week range:
$17.03 - $45.08
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
6.85x
P/B ratio:
3.06x
Volume:
2.7M
Avg. volume:
3.6M
1-year change:
-7.93%
Market cap:
$2.6B
Revenue:
$310.6M
EPS (TTM):
-$2.23
| Period Ending | 2020-04-30 | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | |
|---|---|---|---|---|---|---|
| Revenue | $156.7M | $183.2M | $252.8M | $266.8M | $310.6M | |
| Revenue Growth (YoY) | 71.02% | 16.95% | 37.96% | 5.55% | 16.41% | |
| Cost of Revenues | $38.8M | $44.5M | $63.7M | $86.3M | $132M | |
| Gross Profit | $117.9M | $138.7M | $189M | $180.5M | $178.6M | |
| Gross Profit Margin | 75.24% | 75.7% | 74.79% | 67.64% | 57.49% | |
| R&D Expenses | $64.5M | $68.9M | $150.5M | $210.7M | $201.4M | |
| Selling, General & Admin | $124.8M | $130.1M | $234.6M | $260.3M | $295.5M | |
| Other Inc / (Exp) | -$1.8M | $4M | $3M | $350K | -$641K | |
| Operating Expenses | $189.4M | $199M | $385.2M | $471M | $496.9M | |
| Operating Income | -$71.5M | -$60.3M | -$196.1M | -$290.5M | -$318.3M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$69M | -$55M | -$191.3M | -$268.2M | -$278.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $380K | $704K | $789K | $675K | $792K | |
| Net Income to Company | -$69.4M | -$55.7M | -$192.1M | -$268.8M | -$279.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$69.4M | -$55.7M | -$192.1M | -$268.8M | -$279.7M | |
| Basic EPS (Cont. Ops) | -$0.94 | -$0.90 | -$1.84 | -$2.45 | -$2.34 | |
| Diluted EPS (Cont. Ops) | -$0.94 | -$0.90 | -$1.84 | -$2.45 | -$2.34 | |
| Weighted Average Basic Share | $73.6M | $66.8M | $104.4M | $109.9M | $119.4M | |
| Weighted Average Diluted Share | $73.6M | $66.8M | $104.4M | $109.9M | $119.4M | |
| EBITDA | -$70.2M | -$56M | -$190.9M | -$284.4M | -$305.6M | |
| EBIT | -$71.5M | -$60.3M | -$196.1M | -$290.5M | -$318.3M | |
| Revenue (Reported) | $156.7M | $183.2M | $252.8M | $266.8M | $310.6M | |
| Operating Income (Reported) | -$71.5M | -$60.3M | -$196.1M | -$290.5M | -$318.3M | |
| Operating Income (Adjusted) | -$71.5M | -$60.3M | -$196.1M | -$290.5M | -$318.3M | |
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Revenue | $49.1M | $69.8M | $66.7M | $78.4M | $98.8M | |
| Revenue Growth (YoY) | 18.96% | 42.08% | -4.45% | 17.6% | 26% | |
| Cost of Revenues | $12.2M | $17.4M | $22.3M | $33.1M | $40.4M | |
| Gross Profit | $36.9M | $52.4M | $44.4M | $45.3M | $58.3M | |
| Gross Profit Margin | 75.1% | 75.13% | 66.6% | 57.76% | 59.07% | |
| R&D Expenses | $18.7M | $40.9M | $55.1M | $49.5M | $59.4M | |
| Selling, General & Admin | $36.6M | $58.9M | $61.4M | $78.4M | $86.6M | |
| Other Inc / (Exp) | $1.7M | $7.7M | $2M | $409K | -$957K | |
| Operating Expenses | $55.4M | $99.8M | $116.4M | $127.8M | $145.9M | |
| Operating Income | -$18.5M | -$47.4M | -$72M | -$82.5M | -$87.6M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$16.6M | -$39.3M | -$63M | -$72.1M | -$79.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $203K | $193K | $143K | $489K | $336K | |
| Net Income to Company | -$16.9M | -$39.4M | -$63.2M | -$72.6M | -$80.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$16.9M | -$39.4M | -$63.2M | -$72.6M | -$80.2M | |
| Basic EPS (Cont. Ops) | -$0.23 | -$0.38 | -$0.57 | -$0.60 | -$0.62 | |
| Diluted EPS (Cont. Ops) | -$0.23 | -$0.38 | -$0.57 | -$0.60 | -$0.62 | |
| Weighted Average Basic Share | $78.8M | $105.1M | $110.7M | $120.5M | $130.4M | |
| Weighted Average Diluted Share | $78.8M | $105.1M | $110.7M | $120.5M | $130.4M | |
| EBITDA | -$17.4M | -$46M | -$71.2M | -$79.3M | -$84.5M | |
| EBIT | -$18.5M | -$47.4M | -$72M | -$82.5M | -$87.6M | |
| Revenue (Reported) | $49.1M | $69.8M | $66.7M | $78.4M | $98.8M | |
| Operating Income (Reported) | -$18.5M | -$47.4M | -$72M | -$82.5M | -$87.6M | |
| Operating Income (Adjusted) | -$18.5M | -$47.4M | -$72M | -$82.5M | -$87.6M | |
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Revenue | $172.6M | $232.7M | $266.7M | $296.4M | $366.9M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $42.3M | $58.1M | $78.8M | $122M | $147M | |
| Gross Profit | $130.2M | $174.7M | $187.9M | $174.5M | $220M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $65.6M | $124.9M | $207.4M | $200.4M | $218.6M | |
| Selling, General & Admin | $131.2M | $213.3M | $254.3M | $283.3M | $319.1M | |
| Other Inc / (Exp) | $2.9M | $5.3M | -$2.4M | -$184K | -$1.1M | |
| Operating Expenses | $196.8M | $338.2M | $461.6M | $483.8M | $537.7M | |
| Operating Income | -$66.6M | -$163.5M | -$273.7M | -$309.3M | -$317.8M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$61.5M | -$156.9M | -$261.6M | -$270.7M | -$281.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $553K | $842K | $680K | $1.1M | $794K | |
| Net Income to Company | -$62.1M | -$157.7M | -$262.3M | -$271.7M | -$281.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$62.1M | -$157.7M | -$262.3M | -$271.7M | -$281.9M | |
| Basic EPS (Cont. Ops) | -$0.80 | -$1.54 | -$2.42 | -$2.33 | -$2.23 | |
| Diluted EPS (Cont. Ops) | -$0.80 | -$1.54 | -$2.42 | -$2.33 | -$2.23 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$62.6M | -$158.6M | -$269.1M | -$297M | -$305.3M | |
| EBIT | -$66.6M | -$163.5M | -$273.7M | -$309.3M | -$317.8M | |
| Revenue (Reported) | $172.6M | $232.7M | $266.7M | $296.4M | $366.9M | |
| Operating Income (Reported) | -$66.6M | -$163.5M | -$273.7M | -$309.3M | -$317.8M | |
| Operating Income (Adjusted) | -$66.6M | -$163.5M | -$273.7M | -$309.3M | -$317.8M | |
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Revenue | $130.9M | $180.4M | $194.4M | $224M | $280.3M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $32.8M | $46.4M | $61.4M | $97M | $112M | |
| Gross Profit | $98.1M | $134.1M | $133M | $126.9M | $168.4M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $48.1M | $104.2M | $161M | $150.7M | $168M | |
| Selling, General & Admin | $86.3M | $169.5M | $189.2M | $212.2M | $235.8M | |
| Other Inc / (Exp) | $4.2M | $5.5M | $66K | -$468K | -$916K | |
| Operating Expenses | $134.5M | $273.7M | $350.2M | $363M | $403.8M | |
| Operating Income | -$36.3M | -$139.6M | -$217.2M | -$236M | -$235.5M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$31.2M | -$133.1M | -$203.4M | -$205.9M | -$208.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $456K | $594K | $485K | $863K | $865K | |
| Net Income to Company | -$31.6M | -$133.6M | -$203.9M | -$206.8M | -$209M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$31.6M | -$133.6M | -$203.9M | -$206.8M | -$209M | |
| Basic EPS (Cont. Ops) | -$0.38 | -$1.30 | -$1.87 | -$1.75 | -$1.64 | |
| Diluted EPS (Cont. Ops) | -$0.38 | -$1.30 | -$1.87 | -$1.75 | -$1.64 | |
| Weighted Average Basic Share | $248.7M | $311M | $326.5M | $354.8M | $383.2M | |
| Weighted Average Diluted Share | $248.7M | $311M | $326.5M | $354.8M | $383.2M | |
| EBITDA | -$33.2M | -$135.8M | -$214M | -$226.6M | -$226.2M | |
| EBIT | -$36.3M | -$139.6M | -$217.2M | -$236M | -$235.5M | |
| Revenue (Reported) | $130.9M | $180.4M | $194.4M | $224M | $280.3M | |
| Operating Income (Reported) | -$36.3M | -$139.6M | -$217.2M | -$236M | -$235.5M | |
| Operating Income (Adjusted) | -$36.3M | -$139.6M | -$217.2M | -$236M | -$235.5M | |
| Period Ending | 2020-04-30 | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $33.1M | $115.4M | $339.5M | $284.8M | $167.1M | |
| Short Term Investments | $211.9M | $978M | $620.6M | $446.2M | $583.2M | |
| Accounts Receivable, Net | $30.8M | $65.5M | $80.3M | $134.6M | $130.1M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $5.4M | $14.3M | $20M | $23.3M | $24M | |
| Total Current Assets | $281.2M | $1.2B | $1.1B | $888.9M | $904.4M | |
| Property Plant And Equipment | $8.7M | $6.1M | $14.5M | $84.6M | $88.6M | |
| Long-Term Investments | $725K | -- | $32.1M | $81.4M | -- | |
| Goodwill | $625K | $625K | $625K | $625K | $625K | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $13.8M | $16.6M | $63.2M | $47.5M | $44.6M | |
| Total Assets | $305.1M | $1.2B | $1.2B | $1.1B | $1B | |
| Accounts Payable | $4.7M | $12.1M | $54.2M | $24.6M | $11.3M | |
| Accrued Expenses | $10.2M | $11.2M | $15.7M | $12.3M | $8.2M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | $3.9M | $3.6M | $2.3M | $3.2M | |
| Other Current Liabilities | -- | $2.1M | $1.8M | $3.1M | $1.2M | |
| Total Current Liabilities | $81M | $124.5M | $150.2M | $136M | $102.3M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $487.8M | $135.3M | $181.4M | $173.4M | $164.9M | |
| Common Stock | $31K | $102K | $106K | $113K | $123K | |
| Other Common Equity Adj | $424K | $81K | -$2.1M | -$385K | -$563K | |
| Common Equity | -$182.7M | $1.1B | $989.5M | $929.7M | $873.4M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -$182.7M | $1.1B | $989.5M | $929.7M | $873.4M | |
| Total Liabilities and Equity | $305.1M | $1.2B | $1.2B | $1.1B | $1B | |
| Cash and Short Terms | $245M | $1.1B | $960.2M | $731M | $750.4M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $960.1M | $204.5M | $311.1M | $114.6M | $125.1M | |
| Short Term Investments | $162.9M | $764.1M | $461.3M | $608.8M | $599.2M | |
| Accounts Receivable, Net | $30.2M | $68.2M | $143.7M | $173.5M | $180.4M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $13.5M | $25.8M | $30.4M | $29.2M | $26.2M | |
| Total Current Assets | $1.2B | $1.1B | $946.5M | $926M | $930.9M | |
| Property Plant And Equipment | $6.8M | $5.3M | $75.2M | $91M | $81.9M | |
| Long-Term Investments | -- | $54M | $17.4M | -- | -- | |
| Goodwill | $625K | $625K | $625K | $625K | $625K | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $10.4M | $65M | $55.5M | $46.3M | $41.7M | |
| Total Assets | $1.2B | $1.2B | $1.1B | $1.1B | $1.1B | |
| Accounts Payable | $12.6M | $14.5M | $20M | $19.8M | $28.7M | |
| Accrued Expenses | $14.9M | $10.8M | $14.4M | $9.4M | $22.5M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | $3.2M | $5M | $2.9M | $4.5M | |
| Other Current Liabilities | -- | $4.2M | $5M | $3.7M | $3M | |
| Total Current Liabilities | $104.1M | $129.2M | $123.6M | $109.2M | $138M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $110.5M | $160.8M | $147.8M | $166M | $195M | |
| Common Stock | $101K | $106K | $112K | $121K | $132K | |
| Other Common Equity Adj | $13K | -$796K | -$1M | $430K | $292K | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $1.1B | $1B | $947.4M | $898M | $860.2M | |
| Total Liabilities and Equity | $1.2B | $1.2B | $1.1B | $1.1B | $1.1B | |
| Cash and Short Terms | $1.1B | $968.6M | $772.4M | $723.3M | $724.3M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-04-30 | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$69.4M | -$55.7M | -$192.1M | -$268.8M | -$279.7M | |
| Depreciation & Amoritzation | $1.3M | $4.3M | $5.2M | $6.1M | $12.7M | |
| Stock-Based Compensation | $8.3M | $21.7M | $113.4M | $216.5M | $215.8M | |
| Change in Accounts Receivable | $32.7M | -$34.7M | -$14.2M | -$54.5M | $4.5M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$61.3M | -$37.6M | -$86.5M | -$115.7M | -$62.4M | |
| Capital Expenditures | $2.9M | $1.6M | $4.3M | $71.5M | $28M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$124.1M | -$767.2M | $317M | $59.9M | -$66.6M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $26M | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$3.5M | -- | -$15M | -- | -- | |
| Other Financing Activities | -- | -$7.2M | -$105K | -$6.9M | -$13.2M | |
| Cash From Financing | $119.9M | $887.4M | $5.7M | $621K | $11.3M | |
| Beginning Cash (CF) | $99.1M | $33.6M | $116.3M | $352.5M | $297.4M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$65.5M | $82.7M | $236.3M | -$55.1M | -$117.7M | |
| Ending Cash (CF) | $33.6M | $116.3M | $352.5M | $297.4M | $179.7M | |
| Levered Free Cash Flow | -$64.2M | -$39.2M | -$90.8M | -$187.2M | -$90.4M | |
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$16.9M | -$39.4M | -$63.2M | -$72.6M | -$80.2M | |
| Depreciation & Amoritzation | $1.1M | $1.4M | $844K | $3.2M | $3.1M | |
| Stock-Based Compensation | $6.6M | $31.4M | $55.8M | $55M | $62.7M | |
| Change in Accounts Receivable | $3M | -$41M | -$48.9M | -$30.3M | -$22M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$24.7M | -$55.4M | -$51.9M | -$39.1M | -$22M | |
| Capital Expenditures | $247K | $754K | $19.8M | $6.1M | $362K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $13.4M | $84.5M | $85.9M | $4.1M | $12.4M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$4.4M | -- | -$1.4M | -$711K | -$1.7M | |
| Cash From Financing | $856.8M | $8M | -$858K | $505K | $13.5M | |
| Beginning Cash (CF) | $115.5M | $180.4M | $290.6M | $161.6M | $133.8M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $845.5M | $37.1M | $33.1M | -$34.4M | $3.8M | |
| Ending Cash (CF) | $961M | $217.5M | $323.7M | $127.1M | $137.7M | |
| Levered Free Cash Flow | -$24.9M | -$56.2M | -$71.7M | -$45.1M | -$22.4M | |
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$62.1M | -$157.7M | -$262.3M | -$271.7M | -$281.9M | |
| Depreciation & Amoritzation | $3.9M | $4.9M | $4.7M | $12.3M | $12.5M | |
| Stock-Based Compensation | $17.2M | $85.3M | $204.1M | $207.1M | $231.1M | |
| Change in Accounts Receivable | -$497K | -$37.2M | -$75.8M | -$29.8M | -$8.6M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$40M | -$105M | -$155.9M | -$56.7M | -$31.3M | |
| Capital Expenditures | $1.8M | $3.1M | $62.4M | $36.2M | $4.6M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $64.8M | -$660.1M | $278.1M | -$149M | $19.4M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $26M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$574K | -- | -$12.5M | -$10.3M | |
| Cash From Financing | $885.3M | $21.6M | -$16M | $9.1M | $22.4M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $910.2M | -$743.5M | $106.2M | -$196.6M | $10.5M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$41.8M | -$108.2M | -$218.3M | -$92.9M | -$36M | |
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$31.6M | -$133.6M | -$203.9M | -$206.8M | -$209M | |
| Depreciation & Amoritzation | $3.2M | $3.8M | $3.3M | $9.5M | $9.2M | |
| Stock-Based Compensation | $14.3M | $77.8M | $168.5M | $159M | $174.4M | |
| Change in Accounts Receivable | $588K | -$2M | -$63.6M | -$38.9M | -$52M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$5.8M | -$73.3M | -$142.7M | -$83.7M | -$52.7M | |
| Capital Expenditures | $1.2M | $2.7M | $60.8M | $25.5M | $2.1M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $48.3M | $155.3M | $116.4M | -$92.6M | -$6.5M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $26M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$6.7M | -$105K | -$4.8M | -$10.4M | -$7.5M | |
| Cash From Financing | $885M | $19.2M | -$2.5M | $6M | $17.2M | |
| Beginning Cash (CF) | $278.6M | $571M | $878M | $678M | $459.9M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $927.4M | $101.3M | -$28.8M | -$170.3M | -$42.1M | |
| Ending Cash (CF) | $1.2B | $672.2M | $849.2M | $507.7M | $417.9M | |
| Levered Free Cash Flow | -$7M | -$76M | -$203.5M | -$109.2M | -$54.8M | |
Get AI Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
AI
Sector
P/E ratio
--
20.40x
PEG ratio
-3.98x
0.01x
P/B ratio
3.06x
1.97x
Price / LTM sales
6.85x
1.43x
Growth Metrics
AI
Sector
Revenue growth
26%
4.79%
Earnings growth
--
11.5%
Revenue (5-year growth)
27.66%
6.66%
Earnings forecast
-$0.25
$0.11
Profitability
AI
Sector
Profitability FY 2024
$178.6M
$90.3M
Return on invested capital
-32.29%
0.89%
Return on assets
-26.79%
0.13%
Return on equity
-32.29%
1.81%
Earnings Date
Last Earnings Date
Feb
26
Next Earnings Date
May
29
Estimated Next Earnings Date
May
28
Balance Sheet
AI
Sector
Total cash
$724.3M
$56M
Short term investments
$583.2M
$18.4M
Total assets
$1B
$248.3M
Long term debt
--
$7.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is TSMC the Best Semiconductor Stock to Buy Now?
The new administration has launched a slew of tariffs, paused…
Rocket Lab Vs Intuitive Machines Stock
The commercialization of outer space is now in full swing,…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Sell
43
Is MSFT Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 30x
Sell
40
Is NVDA Stock a Buy?
Market Cap: $2.4T
P/E Ratio: 33x
Alerts
Buy
61
AGX alert for Apr 23
Argan [AGX] is up 3.08% over the past day.
Sell
44
INOD alert for Apr 22
Innodata [INOD] is up 5.26% over the past day.
Sell
44
UHS alert for Apr 22
Universal Health Services [UHS] is up 2.73% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
